Literature DB >> 28361787

IAP Guidelines on Rickettsial Diseases in Children.

Narendra Rathi1, Atul Kulkarni, Vijay Yewale.   

Abstract

OBJECTIVE: To formulate practice guidelines on rickettsial diseases in children for pediatricians across India. JUSTIFICATION: Rickettsial diseases are increasingly being reported from various parts of India. Due to low index of suspicion, nonspecific clinical features in early course of disease, and absence of easily available, sensitive and specific diagnostic tests, these infections are difficult to diagnose. With timely diagnosis, therapy is easy, affordable and often successful. On the other hand, in endemic areas, where healthcare workers have high index of suspicion for these infections, there is rampant and irrational use of doxycycline as a therapeutic trial in patients of undifferentiated fevers. Thus, there is a need to formulate practice guidelines regarding rickettsial diseases in children in Indian context. PROCESS: A committee was formed for preparing guidelines on rickettsial diseases in children in June 2016. A meeting of consultative committee was held in IAP office, Mumbai and scientific content was discussed. Methodology and results were scrutinized by all members and consensus was reached. Textbook references and published guidelines were also used in few instances to make recommendations. Various Indian and international publications pertinent to present study were collated and guidelines were approved by all committee members. Future updates in these guidelines will be dictated by new scientific data in the field of rickettsial diseases in children. RECOMMENDATIONS: Indian tick typhus and scrub typhus are commonly seen rickettsial diseases in India. It is recommended that practicing pediatricians should be well conversant with compatible clinical scenario, suggestive epidemiological features, differential diagnoses and suggestive laboratory features to make diagnosis and avoid over diagnosis of these infections, as suggested in these guidelines. Doxycycline is the drug of choice and treatment should begin promptly without waiting for confirmatory laboratory results.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28361787     DOI: 10.1007/s13312-017-1035-0

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  8 in total

1.  The Need for Geographic Location Specific Optical Density Cut-offs for IgM ELISA Serology to Diagnose Scrub Typhus in Children.

Authors:  Thirunavukkarasu Arun Babu; Dinesh Kumar Narayanasamy
Journal:  Indian Pediatr       Date:  2021-01-15       Impact factor: 1.411

2.  Predictors of Severity in Pediatric Scrub Typhus.

Authors:  Dinesh Kumar Narayanasamy; Thirunavukkarasu Arun Babu; Vijayasankar Vijayadevagaran; Devi Kittu; Shanthi Ananthakrishnan
Journal:  Indian J Pediatr       Date:  2018-01-24       Impact factor: 1.967

3.  Epididymo-Orchitis in Scrub Typhus.

Authors:  Arpan Saha; Sumantra Sarkar; Ashish Patil; Biplab Besra; Chhotan Saha
Journal:  Indian J Pediatr       Date:  2018-04-20       Impact factor: 1.967

4.  Clinical profile and outcome of children with scrub typhus from Chennai, South India.

Authors:  Ramaswamy Ganesh; Natarajan Suresh; L L Pratyusha; Lalitha Janakiraman; Mani Manickam; A Andal
Journal:  Eur J Pediatr       Date:  2018-04-10       Impact factor: 3.183

Review 5.  Infections and the kidney: a tale from the tropics.

Authors:  Nivedita Kamath; Arpana Iyengar
Journal:  Pediatr Nephrol       Date:  2017-09-06       Impact factor: 3.651

6.  Profile of Neurological Manifestations in Children Presenting with Rickettsial Disease.

Authors:  S B Chiranth; K R Ashwini; Vykuntraju K Gowda; K S Sanjay; Maaz Ahmed; G V Basavaraja
Journal:  Indian Pediatr       Date:  2022-01-09       Impact factor: 1.411

7.  A Study of the Profile of Scrub Typhus in a Tertiary Care Hospital in Jharkhand: An Underestimated Problem.

Authors:  Sangita D Kamath; Sarita Kumari; Ashok Sunder
Journal:  Cureus       Date:  2022-07-01

8.  Emerging and Re-emerging Infectious Diseases in South East Asia.

Authors:  Nilendu Sarma
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.